Quantcast
Last updated on April 18, 2014 at 14:18 EDT

Latest biotechnology Stories

2014-04-08 23:02:38

Biotechnology Equipment Markets in China a new research report added to ReportsnReports.com. Dallas, Texas (PRWEB) April 08, 2014 China's demand for biotechnology equipment has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry...

2014-04-08 23:01:27

Forum to Focus On FDA Requirements, Potential Hurdles and Tips for Developing Therapeutic Products Derived from Human Stem Cells Washington (PRWEB) April 08, 2014 DIA will host a forum called “FDA Regulation of Therapeutic Products Derived From Human Stem Cells: Successfully Navigating the Regulatory Hurdles” during the DIA 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19. The Food and Drug Administration (FDA) regulates many therapeutic products derived...

2014-04-08 16:22:59

BEVERLY HILLS, Calif., April 8, 2014 /PRNewswire/ -- Life Stem Genetics, Inc. (LIFS), an emerging company in the advancement of adult stem cell therapies, today announced the appointments of Dr. Roberto Fernandez Vina, Dr. Ranbir Singh Gill, and Dr. Praveen Gill to its Medical Advisory Board. Dr. Roberto Fernandez Vina Born and educated in Argentina, Dr. Roberto Fernandez Vina, MD Cardiology, is a pioneer in the development of multiple adult stem cell therapies, protocols, and...

2014-04-08 16:22:55

Exec to Support Life Science Research Clients in Booming Southwestern Market SALT LAKE CITY, April 8, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. "As we've seen remarkable growth opportunities in the western United States, we knew we needed to bring on new and exceptional...

2014-04-08 12:31:43

Three-Arm Phase I Trials are Being Used to Streamline Biosimilar Development, According to Findings from Decision Resources Group BURLINGTON, Mass., April 8, 2014 /PRNewswire/ -- Decision Resources Group finds that partnership activity in the biosimilar space increased 34 percent in 2013 compared with 2012. This increase was driven by biosimilar developers recognizing the need to augment their internal capabilities with those of an increasing number of market players looking to enter the...

2014-04-08 12:30:51

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fv78n3/cardiovascular) has announced the addition of a new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/fv78n3/cardiovascular ] to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from...

2014-04-08 12:22:32

ALBANY, New York, April 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" the global synthetic biologymarket was valued at USD 1.8 billion in 2012 and is estimated to reach a market worth of USD 13.4 billion...

2014-04-08 12:22:30

DALLAS, April 8, 2014 /PRNewswire/ -- The report "Protein Hydrolysis Enzymes Market by Sources (Microorganisms, Animals, Plants), Applications (Detergent Industry, Pharmaceuticals, Food Industry and Others), & Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019" defines and segments the global protease enzymes market with an analysis of the market value by sources and applications of protease enzymes. The report also identifies...

2014-04-08 08:32:20

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/492nrm/gene_therapy) has announced the addition of a new report "Gene Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/492nrm/gene_therapy ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Gene therapy can be broadly defined as the transfer of defined genetic material to specific target...

2014-04-08 08:32:08

SHANGHAI, April 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that it has received an honorable mention award at the International Society for Pharmaceutical Engineering's (ISPE) 2014 Facility of the Year Awards for the company's recently completed cGMP cell-culture-based biologics production facility in Wuxi. These...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »